Search

Your search keyword '"Bellavia G"' showing total 152 results
Start Over Author "Bellavia G"
152 results on '"Bellavia G"'

2. Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: Results from a cross-sectional survey on 7,014 workers in healthcare

Author

Ughi, N, Del Gaudio, F, Dicuonzo, A, Orso, M, Micheloni, G, Puoti, M, Pani, A, Scaglione, F, Zoppini, L, Rossetti, C, Epis, O, Bellavia, G, Giroldi, S, Moreno, M, Bosio, M, Ughi N., Del Gaudio F., Dicuonzo A., Orso M., Micheloni G., Puoti M., Pani A., Scaglione F., Zoppini L., Rossetti C., Epis O. M., Bellavia G., Giroldi S., Moreno M., Bosio M., Ughi, N, Del Gaudio, F, Dicuonzo, A, Orso, M, Micheloni, G, Puoti, M, Pani, A, Scaglione, F, Zoppini, L, Rossetti, C, Epis, O, Bellavia, G, Giroldi, S, Moreno, M, Bosio, M, Ughi N., Del Gaudio F., Dicuonzo A., Orso M., Micheloni G., Puoti M., Pani A., Scaglione F., Zoppini L., Rossetti C., Epis O. M., Bellavia G., Giroldi S., Moreno M., and Bosio M.

Abstract

OBJECTIVE: This study aimed to improve the post-marketing surveillance on mRNA anti-SARS-CoV-2 vaccines, characterizing the adverse events (AEs) after the first dose of mRNA BNT162b vaccine. The associations between the AEs and individuals' characteristics were explored. PATIENTS AND METHODS: All adult healthcare workers at Niguarda Hospital (Milan, Italy) who were referred for the first dose of vaccine were offered to participate in a cross-sectional survey during the second-dose administration, between 18 January and 7 February 2021. All participants completed a questionnaire about age, gender, weight, height, medical history, concurrent therapies, employment status, previous diagnosis/testing for SARS-CoV-2 infection, and a list of 24 AEs (solicited AEs). The development of at least one solicited AEs was the main outcome. AEs were stratified by the presence of injection-site symptoms, systemic symptoms or both, and the differences between strata were assessed as a secondary outcome. Biometric data and reports of a previous diagnosis of SARS-CoV-2 infection were also explored, as predictors of the main outcome. RESULTS: 7,014 healthcare workers were included. An incidence of 3 per 10.000 persons for serious AEs following the first administration of the mRNA BNT162b vaccine was found. An association between the development of non-serious AEs with young age, female gender, low body mass index, and previous history of SARSCoV- 2 was described. CONCLUSIONS: This real-life study supported data on the safety profile of the BNT162b2 mRNA vaccine. Our findings on the associations between the development of non-serious AEs with some individual characteristics may help physicians and patients make educated and informed medical decisions towards anti-COVID-19 vaccination.

Published
2021

5. Gastric metastasis from breast cancer

Author

Gebbia V., Bellavia G., Bajardi E. A., Arcara C., Ancona C., Vaccaro G., Cipolla C., Graceffa G., Valerio M. R., Gebbia V., Bellavia G., Bajardi E.A., Arcara C., Ancona C., Vaccaro G., Cipolla C., Graceffa G., and Valerio M.R.

Subjects
stomach metastasis, breast cancer, gastric metastasis
Abstract

Introduction: Breast carcinoma is the most common malignancy in women and the main cause of tumor deaths. Despite early recognition by screening and improvement in treatment regimens, many patients will eventually develop metastases, either locoregional recurrences or distant metastases, most frequently in the skeleton, liver and lung. Metastases to the gastrointestinal tract are infrequent and not even mentioned in the major oncologic textbooks. Case presentation: We report a case of metastasis to the stomach from occult breast cancer. The diagnosis was established by computed tomography (CT), histologic and immunohistochemical analyses of biopsies of the stomach lesion. The patient was treated with pre-operative hormonal therapy, undergoes breast surgery and then treated with systemic chemotherapy. She is still alive 2 years after initial symptoms of dyspepsia. Conclusion: The differentiation between primary gastric cancer and a metastatic breast tumor to the stomach is important for planning of treatment and to spare the patient unnecessary gastric surgery.

Published
2020

7. Personalizing Cancer Pain Therapy: Insights from the Rational Use of Analgesics (RUA) Group

Author

Varrassi, G., Coluzzi, F., Guardamagna, V. A., Puntillo, F., Sotgiu, G., Vellucci, R., Abrardi, L., Aiello, A., Albanese, G. V., Alongi, A., Altavilla, L., Ambrosio, R., Ammirati, L. A., Bacchini, G. P., Balbi, V., Ballarin, S., Balloni, A. G., Bambagioni, V., Bellavia, G., Berte', R., Bertolini, F., Bertolucci, A., Bilani, V., Bonafede, E. V., Bonato, C., Bondi, F., Bosco, M., Bottino, F., Branca, B., Brizio, A., Brogi, L., Brollo, M., Bruera, G., Brusco, G., Burato, A. M., Caiozzi, S. F., Calabrese, G., Calligaris, M., Cantisani, E., Capecchi, S., Caponi, S., Carbone, M., Carella, C., Careri, M. C., Carnicella, A., Caruso, M. L., Catania, E., Cavo, A., Cianci, G., Cocchiarella, A., Colombo, L., Corsi, G., Cortinovis, R., Costantini, S., Crispi, M., Cuccu, G., Cuomo, A., Dalia, P., D'Amato, G., De Chirico, C., De Clementi, M., De Gasperi, M., De Lisi, A., De Lucia, L., De Martino, G., De Toni, P., De Tursi, M., Defendi, S., Degl'Innocenti, M., Santi, I. D., Destro, M., Di Bartolomeo, C., Di Ciaula, G., Di Fonzo, C., Di Maggio, G., Di Matteo, S., Di Paolo, A., Di Trapani, M. C., Di Zio, I., Diodati, M., Dongiovanni, D., D'Urso, M., Fabiani, M. G., Facciuto, P., Falco, V., Faraone, E., Fasano, M., Ferrara, P., Florian, C., Fora, G., Fornaro, F., Forno, B., Fortis, M., Foti, S., Friolo, D., Gabris, A., Galanti, D., Galizia, B., Gallo, P., Gaudio, L., Gentili, G., Ginex, G., Giuliani, J., Gobber, G., Amerelli, A. G., Gorgni, S., Gucciardino, C., Ieri, T., Ingui', M., Jamara, G., La Sala, A., Lattuca, P., Mauro, M. L., Luigini, A., Luisi, D., Lungu, V., Mabilia, R., Macaluso, S., Maglio, A., Magnapera, A., Maione, A., Malorgio, F., Mancuso, A., Manni, A., Marchesi, R., Mariani, M., Martini, A., Massetti, M., Mauceri, M., Melo, M., Merlotti, R., Modugno, D., Montagna, M. C., Montanari, L., Napolitano, G., Nicodemo, M., Orlandini, G., Orlandini, F., Orsi, P., Pacifico, C., Pagliaro, E., Paladini, A., Paolucci, V., Pascazio, A., Pastore, A., Patanella, I., Pedaci, E., Pellegrini, A., Pellerito, N., Pepe, V., Petreni, P., Piazza, S., Picchi, M., Piccinelli, G., Pignatelli, A., Pinta, F., Pinto, T., Piovano, P. L., Pirajno, G., Pollastrini, C., Potenza, I., Provenzano, A., Provinciali, N., Puglia, L., Putignano, D., Ranucci, A., Ravoni, G., Redivo, L., Ricchini, F., Rizzi, F., Romoli, M., Ronga, G., Rosafio, I., Roselli, L., Russano, M., Russo, P., Saetta, A., Sarnelli, R., Sartori, S., Saviola, A., Scandone, F., Scibilia, C., Silverj, E., Sosta, E., Sparacino, M. E., Tavella, E., Tempera, S., Terranova, A., Tomasini, V., Trivellato, E., Vallisneri, C., Vannini, A., Vassillo, M., Verni, P., Visconti, E., Zaza, A., and Zizzetti, S.

Subjects
medicine.medical_specialty, Palliative care, business.industry, Pain medicine, Breakthrough pain, Cancer pain, Opioid-induced bowel dysfunction (OIBD), Opioid-induced constipation (OIC), Opioids, Delphi method, Likert scale, Anesthesiology and Pain Medicine, Opioid, Multidisciplinary approach, Interquartile range, Family medicine, Medicine, Neurology (clinical), business, medicine.drug
Abstract

A previous Delphi survey from the Rational Use of Analgesics (RUA) project involving Italian palliative care specialists revealed some discrepancies between current guidelines and clinical practice with a lack of consensus on items regarding the use of strong opioids in treating cancer pain. Those results represented the basis for a new Delphi study addressing a better approach to pain treatment in patients with cancer. The study consisted of a two-round multidisciplinary Delphi study. Specialists rated their agreement with a set of 17 statements using a 5-point Likert scale (0 = totally disagree and 4 = totally agree). Consensus on a statement was achieved if the median consensus score (MCS) (expressed as value at which at least 50% of participants agreed) was at least 4 and the interquartile range (IQR) was 3–4. This survey included input from 186 palliative care specialists representing all Italian territory. Consensus was reached on seven statements. More than 70% of participants agreed with the use of low dose of strong opioids in moderate pain treatment and valued transdermal route as an effective option when the oral route is not available. There was strong consensus on the importance of knowing opioid pharmacokinetics for therapy personalization and on identifying immediate-release opioids as key for tailoring therapy to patients’ needs. Limited agreement was reached on items regarding breakthrough pain and the management of opioid-induced bowel dysfunction. These findings may assist clinicians in applying clinical evidence to routine care settings and call for a reappraisal of current pain treatment recommendations with the final aim of optimizing the clinical use of strong opioids in patients with cancer.

Published
2021

9. Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare.

Author

UGHI, N., DEL GAUDIO, F., DICUONZO, A., ORSO, M., MICHELONI, G., PUOTI, M., PANI, A., SCAGLIONE, F., ZOPPINI, L., ROSSETTI, C., EPIS, O. M., BELLAVIA, G., GIROLDI, S., MORENO, M., and BOSIO, M.

Abstract

OBJECTIVE: This study aimed to improve the post-marketing surveillance on mRNA anti-SARS-CoV-2 vaccines, characterizing the adverse events (AEs) after the first dose of mRNA BNT162b vaccine. The associations between the AEs and individuals' characteristics were explored. PATIENTS AND METHODS: All adult healthcare workers at Niguarda Hospital (Milan, Italy) who were referred for the first dose of vaccine were offered to participate in a cross-sectional survey during the second-dose administration, between 18 January and 7 February 2021. All participants completed a questionnaire about age, gender, weight, height, medical history, concurrent therapies, employment status, previous diagnosis/testing for SARS-CoV-2 infection, and a list of 24 AEs (solicited AEs). The development of at least one solicited AEs was the main outcome. AEs were stratified by the presence of injection-site symptoms, systemic symptoms or both, and the differences between strata were assessed as a secondary outcome. Biometric data and reports of a previous diagnosis of SARS-CoV-2 infection were also explored, as predictors of the main outcome. RESULTS: 7,014 healthcare workers were included. An incidence of 3 per 10.000 persons for serious AEs following the first administration of the mRNA BNT162b vaccine was found. An association between the development of non-serious AEs with young age, female gender, low body mass index, and previous history of SARSCoV-2 was described. CONCLUSIONS: This real-life study supported data on the safety profile of the BNT162b2 mRNA vaccine. Our findings on the associations between the development of non-serious AEs with some individual characteristics may help physicians and patients make educated and informed medical decisions towards anti-COVID-19 vaccination. [ABSTRACT FROM AUTHOR]

Published
2021

10. Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study.

Author

SCHIANCHI, A., UGHI, N., CASSANO, G., DEL GAUDIO, F., DICUONZO, A., SCAGLIONE, F., ALBERTI, P. M., ROSSETTI, C., MICHELONI, G., ZOPPINI, L., BELLAVIA, G., GIROLDI, S., MORENO, M., RUSSO, A., BOSIO, M., and EPIS, O. M.

Abstract

OBJECTIVE: Anti-COVID-19 vaccines were mainly associated with non-serious adverse events (AEs), whose prevalence was reported to be up to 70% in healthcare workers (HCWs). This may lead to sick leave requests, but this impact has never been quantified. This study aimed to investigate the absence from work among HCWs following anti-COVID-19 vaccination. Its association with age and previous COVID-19 infection was also assessed. PATIENTS AND METHODS: This is a retrospective observational cross-sectional study on administrative data about sick leave requests after anti-COVID-19 vaccination. All the HCWs employed at the Niguarda Hospital (Milan, Italy) who received the vaccine from December 27, 2020 to February 28, 2021 were included. RESULTS: In total, 4,088 HCWs received the first dose of the vaccine and 4,043 completed the vaccination cycle. After the first injection, 1.6% of HCWs requested sick leave, while after the second injection, the number of requests significantly increased (+6.1%, p<0.001). A significant increase in sick leave was detected for those who have had SARS-CoV-2 infection after the first injection (+2.3%, p<0.001). After the second dose, a significant increase in sick leave was observed in the 20-30-year-old group compared to >30 years (+3.6%, p=0.017), if HCWs without a history of SARS-CoV-2 infection were considered. CONCLUSIONS: The requests for sick leave among HCWs following the anti-COVID-19 vaccine were limited and higher after the second injection. This may help the management of the human resources when the large-scale administration of the anti-COVID-19 vaccines will involve other categories of workers. [ABSTRACT FROM AUTHOR]

Published
2021

13. Urinary dysfunction in Parkinson’s disease patients

Author

Valentino, F., Arnao, V., Realmuto, S., Cinturino, A., Mastrilli, S., Perini, V., Bellavia, G., Dispensa, N., Bartolotta, T., Pavone, C., D'Amelio, M., Valentino, F, Arnao, V, Realmuto, S, Cinturino, A, Mastrilli, S, Perini, V, Bellavia, G, Dispensa, N, Bartolotta, T, Pavone, C, and D'Amelio, M

Subjects
Parkinson's disease, autonomic nervous system, Settore MED/26 - Neurologia
Abstract

Background: Autonomic nervous system dysfunction that affects 70–80% of Parkinson’s disease (PD) patients, causes significant morbidity and it is correlated with poor quality of life. Objective: We assessed in a consecutive series of PD patients frequency of autonomic symptoms by means of the Scale for Outcomes for Parkinson’s disease AUTonomic (SCOPA-AUT) and we correlated it with the results of noninvasive urological studies (nUS). Methods: PD patients with known conditions that might have influenced urinary function were excluded. Clinical assessment of PD patients included the H&Y staging, UPDRS, BDI, NPI, PDQ- 39, PDSS, ESS, and the SCOPA-AUT scale. nUS consisted of uroflowmetry and ultrasound of the urinary tract with measurement of postvoid residual (PVR) urine volume. The quantitative parameters measured during the voiding phase included maximum flow rate (Qmax) and postvoid residual (PVR). Results: 45 PD patients (26 males and 19 females) were included (mean age at interview 62.1 ± 10.6; mean disease duration: 6.5 ± 4.3 years). PD patients had a mean SCOPA-AUT score of 14.1 ± 7.1. PD patients with urinary dysfunction, had higher SCOPA-AUT scale score, longer disease duration and an higher dosage of levodopa calculated as levodopa equivalent dose (LED). At least one clinical symptom of dysautonomia was found in all of our PD patients and urinary symptoms were the most common complain (92.8%). The mean Qmax was 17.9 ml/s (SD 9.1 ml/s), and the mean PVR was 33.7 ml (SD 68.7 ml), with no patient having a PVR>200 ml. Ultrasound documented possible causes of urinary disorders in 44% of patients (prostate hypertrophy was observed in 11 of 26 males). Conclusion: Our findings suggest that urinary symptoms and abnormal findings in nUS are common in PD patients. The autonomic dysfunction might be related to nigrostriatal degeneration, though urinary dysfunction in patients PD could be, especially in males,attributed to other conditions

Published
2016

14. Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents

Author

Bellavia G, Francesco Ferraù, Vittorio Gebbia, Maria Rosaria Valerio, Gebbia, V, Bellavia, G, Ferraù, F, and Valerio, MR

Subjects
medicine.medical_specialty, Settore MED/06 - Oncologia Medica, Poor compliance, medicine.medical_treatment, Administration, Oral, Antineoplastic Agents, Pharmacology, Socioeconomic Factor, Medication Adherence, Persistence (computer science), Persistence, Antineoplastic Agent, Immunologic Factor, Neoplasms, Humans, Immunologic Factors, Medicine, Pharmacology (medical), Intensive care medicine, Oral therapy, Cancer, Chemotherapy, business.industry, Health Care Costs, General Medicine, Drug adherence, medicine.disease, Biologic Agents, Health Care Cost, Hospitalization, Socioeconomic Factors, Adherence, Neoplasm, business, Oral chemotherapy, Human, Medical literature
Abstract

Introduction: To date, orally administered chemotherapy and biologic agents represent a significant percentage of all antineoplastic treatments in several types of cancer, which are most likely to increase in the near future. In this scenario, the issue of adherence and persistence to oral therapy is a key issue since poor compliance to oral antineoplastic treatments may negatively influence patients' clinical outcomes and, in turn, cause an increase in costs, number of hospitalizations and time spent in the hospital. Areas covered: The issue of adherence to new oral chemotherapeutic and/or biologic agents has not been deeply evaluated and data published in medical literature are quite scarce. Adherence is a multidimensional phenomenon, which may be influenced by patient-and health-care provider-related factors, anticancer therapy itself, education and socioeconomic aspects. Patients' selection plays, therefore, a key role in maximizing adherence and persistence to oral therapies. Treating health-care practitioners should first evaluate patient reliability to avoid prescribing oral treatments to patients with socioeconomic and medical conditions, which may predict poor adherence. Expert opinion: Adherence and persistence to new oral biologic agents, which are linked to several side effects and whose use is constantly widening, should represent a main endpoint of clinical research in the nearest future. © 2012 Informa UK, Ltd.

Published
2011
Full Text
View/download PDF

15. Protein Thermal Denaturation and Matrix Glass Transition in Different Protein−Trehalose−Water Systems

Author

Antonio Cupane, Bellavia G, Grazia Cottone, Sergio Giuffrida, Lorenzo Cordone, Bellavia, G, Giuffrida, S, Cottone, G, Cupane, A, and Cordone, L

Subjects
Protein Denaturation, denaturation, Molecular Dynamics Simulation, Phase Transition, DSC, Matrix (chemical analysis), Hemoglobins, chemistry.chemical_compound, Differential scanning calorimetry, Materials Chemistry, Animals, glass transition, Physical and Theoretical Chemistry, trehalose, Settore CHIM/02 - Chimica Fisica, Chromatography, Calorimetry, Differential Scanning, Myoglobin, Temperature, Proteins, Water, Serum Albumin, Bovine, Trehalose, Settore FIS/07 - Fisica Applicata(Beni Culturali, Ambientali, Biol.e Medicin), Surfaces, Coatings and Films, Amorphous solid, chemistry, Chemical engineering, confinement, Cattle, Muramidase, Lysozyme, Ternary operation, Glass transition
Abstract

Biopreservation by saccharides is a widely studied issue due to its scientific and technological importance; in particular, ternary amorphous protein-saccharide-water systems are extensively exploited to model the characteristics of the in vivo biopreservation process. We present here a differential scanning calorimetry (DSC) study on amorphous trehalose-water systems with embedded different proteins (myoglobin, lysozyme, BSA, hemoglobin), which differ for charge, surface, and volume properties. In our study, the protein/trehalose molar ratio is kept constant at 1/40, while the water/sugar molar ratio is varied between 2 and 300; results are compared with those obtained for binary trehalose-water systems. DSC upscans offer the possibility of investigating, in the same measurement, the thermodynamic properties of the matrix (glass transition, T(g)) and the functional properties of the encapsulated protein (thermal denaturation, T(den)). At high-to-intermediate hydration, the presence of the proteins increases the glass transition temperature of the encapsulating matrix. The effect mainly depends on size properties, and it can be ascribed to confinement exerted by the protein on the trehalose-water solvent. Conversely, at low hydration, lower T(g) values are measured in the presence of proteins: the lack of water promotes sugar-protein interactions, thus weakening the confinement effect and softening the matrix with respect to the binary system. A parallel T(den) increase is also observed; remarkably, this stabilization can reach ∼70 K at low hydration, a finding potentially of high biotechnological relevance. A linear relationship between T(g) and T(den) is also observed, in line with previous results; this finding suggests that collective water-trehalose interactions, responsible for the glass transition, also influence the protein denaturation.

Published
2011
Full Text
View/download PDF

16. Atypical Post-Injection Reactions with Delayed Onset Following Glatiramer Acetate 40 mg: Need for Titration?

Author

Zecca, Chiara, primary, Bellavia, G., additional, Brambilla, L., additional, Gutierrez, L. P., additional, Gerardi, C., additional, Fiori, A. M., additional, Bernardini, L. R., additional, Camera, G., additional, Disanto, G., additional, Petrini, L., additional, Perugini, J., additional, Antozzi, C. G., additional, Torri Clerici, V., additional, Bellino, A., additional, Confalonieri, P. A., additional, Gobbi, C., additional, Mantegazza, R. E., additional, and Rossi, S., additional

Published
2018
Full Text
View/download PDF

17. A Multi-Dimensional Assessment of the Conservative Technologies Used for the Treatment of Uterine Fibroids in Italy

Author

Ferrario, L, primary, Foglia, E, additional, Garagiola, E, additional, Gerardi, C, additional, Bellavia, G, additional, Colombo, S, additional, Ticca, C, additional, Rossetti, C, additional, Ciboldi, M, additional, Meroni, MG, additional, Vanzulli, A, additional, Rampoldi, AG, additional, Bignardi, T, additional, Porazzi, E, additional, and Croce, D, additional

Published
2017
Full Text
View/download PDF

18. Quetiapine dose-sparing effect with addiction of memantine: two cases report of Lewy Body disease and dementia associated with Parkinson’s disease

Author

REALMUTO, Sabrina, MASTRILLI, Sergio, Arnao, Valentina, CINTURINO, Antonio, MAZZOLA, Maria Antonietta, TALAMANCA, Simona, D'AMELIO, Marco, PICCOLI, Tommaso, CUPIDI, Chiara, Di Gesaro, L, Riolo, M, Cusmano, I, Bellavia, G, Realmuto, S, Mastrilli, S, Di Gesaro, L, Riolo, M, Cusmano, I, Arnao, V, Cinturino, A, Mazzola, MA, Talamanca, S, Bellavia, G, D’Amelio, M, Piccoli, T, and Cupidi C

Subjects
memantine, dementia
Published
2012

19. The Citrus in the Mediterranean Region

Author

INGLESE, Paolo, Pensabene Bellavia, G., Vacante, V, Gerson, U, Inglese, P, and Pensabene Bellavia, G

Subjects
Settore AGR/03 - Arboricoltura Generale E Coltivazioni Arboree, citrus
Published
2012

20. Computer-assisted cognitive remediation for Parkinson’s disease

Author

Dibilio, V, Nicoletti, Alessandra, D’Amelio, M, Cerasa, A, Bellavia, G, Di Gesaro, L, Gioia, Mc, Maci, T, Le Pira, F, Realmuto, S, Salsone, M, Sanfilippo, C, Savettieri, G, Quattrone, A, Zappia, Mario, Dibilio, V, Nicoletti, A, D'Amelio, M, Cerasa, A, Bellavia, G, Di Gesaro, L, Gioia, MC, Maci, T, Le Pira, F, Realmuto, S, Salsone, M, Sanfilippo, M, Savettieri, G, Quattrone, A, and Zappia, M

Subjects
computer-assisted cognitive training, parkinson's disease, Settore MED/26 - Neurologia
Published
2012

21. DEVELOPMENT OF AN ANTHROPOMORPHIC MODEL FOR VEHICLE – PEDESTRIAN CRASH TEST

Author

Bellavia, G, VIRZI' MARIOTTI, Gabriele, Bellavia, G, and Virzi Mariotti, G

Subjects
Biomechanics, Crash test, Pedestrian Dummy, Settore ING-IND/14 - Progettazione Meccanica E Costruzione Di Macchine
Abstract

The purpose of this work is the achievement of an anthropomorphic model for the virtual simulation of pedestrian – vehicle crash test. “Dummy” construction in Visual Nastran room does possible the preparation of crash test with several vehicle models. Its three-dimensional geometry is implemented by video animation software, extracting the geometry element for element, and its characteristics are in keeping with EURONCAP protocol. Every bodily segment properties are determined using the reference material on the movement biomechanics. At last fall tests from three different heights are simulated for the “Dummy” validation, obtaining a reliable result.

Published
2009

23. MULTIBODY NUMERICAL SIMULATION FOR VEHICLE – PEDESTRIAN CRASH TEST

Author

VIRZI' MARIOTTI, Gabriele, Bellavia, G., Virzi' Mariotti, G, and Bellavia, G

Subjects
Settore ING-IND/14 - Progettazione Meccanica E Costruzione Di Macchine, Crash Test, Pedestrian-vehicle, HIC
Abstract

The purpose of this paper is the simulation of vehicle – pedestrian crash test, executed by Visual Nastran. The evaluation of the damage caused to pedestrian is obtained following the EURONCAP directive. The vehicle virtual model, DIMA, follows closely the characteristics of a saloon car belonging to the small cars category. A total of 16 simulation tests are conduced; each characterized by different initial conditions. The vehicle advances with several speeds, at constant speed and in braking. The anthropomorphic model Dummy impacts with the vehicle in lateral or perfectly frontal position with respect to the front of the vehicle.

Published
2009

25. COENZIMA Q E MALATTIA DI PARKINSON

Author

GIUNTA A, DI PRIMA, Anna, BELVEDERE G, FERLISI M, LO BUE A, BELLAVIA G, BRUCATO V, DOMINGUEZ RODRIGUEZ, Ligia Juliana, BARBAGALLO, Mario, BELVEDERE, Mario, GIUNTA A, DI PRIMA A, BELVEDERE G, FERLISI M, LO BUE A, BELLAVIA G, BRUCATO V, DOMINGUEZ LJ, BARBAGALLO M, and BELVEDERE M

Subjects
M. di Parkinson, coenzima Q
Published
2008

27. DOMOTICA, UTENZA DEBOLE E ANZIANI

Author

BELVEDERE MARCO, GIUNTA A, SPATAFORA G, BELLAVIA G, DI PRIMA, Anna, AGLIALORO, Claudia, CARDO SANTO, Salvatore, DOMINGUEZ RODRIGUEZ, Ligia Juliana, BARBAGALLO, Mario, BELVEDERE, Mario, BELVEDERE MARCO, DI PRIMA A, GIUNTA A, SPATAFORA G, BELLAVIA G, AGLIALORO C, CARDO SANTO S, DOMINGUEZ LJ, BARBAGALLO M, and MARIO BELVEDERE

Published
2007

28. DEPRESSIONE, ANZIANI E PSICOTERAPIA

Author

DI PRIMA, Anna, AGLIALORO, Claudia, DOMINGUEZ RODRIGUEZ, Ligia Juliana, BARBAGALLO, Mario, BELVEDERE, Mario, BELVEDERE G, FERLISI M, LO BUE A, BELLAVIA G, DI PRIMA A, BELVEDERE G, FERLISI M, LO BUE A, BELLAVIA G, AGLIALORO C, DOMINGUEZ LJ, BARBAGALLO M, and BELVEDERE M

Published
2007

33. SINTOMI COGNITIVI E DEPRESSIVI IN SOGGETTI NON DEMENTI CON MALATTIA CEREBROVASCOLARE SOTTOCORTICALE

Author

LO BUE A, BELVEDERE G, FERLISI M, BELLAVIA G, DI PRIMA, Anna, CARDO SANTO, Salvatore, AGLIALORO, Claudia, FERLISI, Annalisa, LARGUECHE, Selma, DOMINGUEZ RODRIGUEZ, Ligia Juliana, BARBAGALLO, Mario, BELVEDERE, Mario, LO BUE A, BELVEDERE G, FERLISI M, DI PRIMA A, CARDO SANTO S, AGLIALORO C, BELLAVIA G, FERLISI A, LARGUECHE S, DOMINGUEZ LJ, BARBAGALLO M, and BELVEDERE M

Published
2007

34. HOMOCYSTEINE AND OXIDATIVE STRESS IN HYPERTENSIVE AND DIABETIC OLDER PATIENTS

Author

DOMINGUEZ RODRIGUEZ, Ligia Juliana, GALIOTO, Antonio, FERLISI, Annalisa, PUTIGNANO, Ernesto, BELVEDERE, Mario, COSTANZA, Giuseppe, BARBAGALLO, Mario, PIENO A, BELLAVIA G, DOMINGUEZ LJ, GALIOTO A, PIENO A, FERLISI A, BELLAVIA G, PUTIGNANO E, BELVEDERE M, COSTANZA G, and BARBAGALLO M

Published
2007

37. DISTURBI D’ANSIA NELL’ANZIANO

Author

BELVEDERE G, FERLISI M, BELLAVIA G, DI PRIMA, Anna, AGLIALORO, Claudia, ARIZZI, Carmela Rosaria, LARGUECHE, Selma, DOMINGUEZ RODRIGUEZ, Ligia Juliana, BARBAGALLO, Mario, BELVEDERE, Mario, BELVEDERE G, DI PRIMA A, AGLIALORO C, FERLISI M, ARIZZI C, LARGUECHE S, BELLAVIA G, DOMINGUEZ LJ, BARBAGALLO M, and BELVEDERE M

Published
2007

38. I LUOGHI DELLA CURA E DEL MORIRE: REPARTO DI GERIATRIA: TRE ANNI DI ATTIVITÀ

Author

LO BUE A, FERLISI M, GIUNTA A, BELVEDERE G, BELLAVIA G, MARCHESE G, DI PRIMA, Anna, DOMINGUEZ RODRIGUEZ, Ligia Juliana, BARBAGALLO, Mario, BELVEDERE, Mario, LO BUE A, FERLISI M, GIUNTA A, DI PRIMA A, BELVEDERE G, BELLAVIA G, MARCHESE G, DOMINGUEZ LJ, BARBAGALLO M, and BELVEDERE M

Published
2006

39. RIABILITAZIONE NEUROMOTORIA NELLA M. DI PARKINSON: CONDIZIONAMENTO SENSORIALE

Author

FERLISI M, BELVEDERE G, BELLAVIA G, LO BUE A., DI PRIMA, Anna, ARIZZI, Carmela Rosaria, TRANCHINA, Ernesto, DOMINGUEZ RODRIGUEZ, Ligia Juliana, BARBAGALLO, Mario, BELVEDERE, Mario, FERLISI M, DI PRIMA A, BELVEDERE G, ARIZZI C, TRANCHINA E, BELLAVIA G, DOMINGUEZ LJ, BARBAGALLO M, BELVEDERE M, and LO BUE A

Published
2006

40. PREVENZIONE NELLE MALATTIE NEURODEGENERATIVE NELL’ANZIANO

Author

BELLAVIA G, LO BUE A, GIUNTA A, FERLISI M, DOMINGUEZ RODRIGUEZ, Ligia Juliana, BARBAGALLO M., BELVEDERE, Mario, AGLIALORO, Claudia, ZAGONE, Giovanni, BELLAVIA G, LO BUE A, BELVEDERE M, AGLIALORO C, GIUNTA A, ZAGONE G, FERLISI M, DOMINGUEZ LJ, and BARBAGALLO M

Published
2006

41. MISURARE LA FRAGILITÀ DEL PAZIENTE ONCOLOGICO ANZIANO

Author

BELLAVIA G, AGUELI R, GRASSO V, DOMINGUEZ RODRIGUEZ, Ligia Juliana, DELEO, Maria, BELVEDERE, Mario, PUTIGNANO, Ernesto, GEBBIA, Vittorio, BARBAGALLO, Mario, BELLAVIA G, DOMINGUEZ LJ, DELEO M, BELVEDERE M, PUTIGNANO E, GEBBIA V, AGUELI R, GRASSO V, and BARBAGALLO M

Published
2006

42. HOSPICE E TERMINALITÀ IN PAZIENTI CON DEMENZA

Author

DI PRIMA, Anna, BELVEDERE, Mario, FERLISI, Annalisa, DOMINGUEZ RODRIGUEZ, Ligia Juliana, BARBAGALLO, Mario, LO BUE A, FERLISI M, GIUNTA A, BELLAVIA G, BELVEDERE M., DI PRIMA A, LO BUE A, FERLISI M, BELVEDERE M, FERLISI A, GIUNTA A, BELLAVIA G, DOMINGUEZ LJ, and BARBAGALLO M

Published
2006

43. PREVENZIONE DELLE MALATTIE NEURODEGENERATIVE NELL’ANZIANO

Author

FERLISI, Annalisa, BELVEDERE, Mario, AGLIALORO, Claudia, ZAGONE, Giovanni, DOMINGUEZ RODRIGUEZ, Ligia Juliana, BARBAGALLO, Mario, FERLISI M, BELLAVIA G, LO BUE A, GIUNTA A, BELVEDERE M., FERLISI A, FERLISI M, BELLAVIA G, LO BUE A, BELVEDERE M, AGLIALORO C, GIUNTA A, ZAGONE G, DOMINGUEZ LJ, and BARBAGALLO M

Published
2006

44. CO-MORBILITA’ E DEPRESSIONE NELL’ANZIANO

Author

BELVEDERE G, LO BUE A, FERLISI M, GIUNTA A, BELLAVIA G, BRUCATO V, DI PRIMA, Anna, DOMINGUEZ RODRIGUEZ, Ligia Juliana, BELVEDERE, Mario, BELVEDERE G, LO BUE A, FERLISI M, GIUNTA A, BELLAVIA G, BRUCATO V, DI PRIMA A, DOMINGUEZ LJ, and BELVEDERE M

Published
2006

45. Blender

Author

Guidazzoli, A., primary, Imboden, S., additional, De Luca, D., additional, Verri, L., additional, Liguori, M. C., additional, Bellavia, G., additional, and Baglivo, A., additional

Published
2016
Full Text
View/download PDF

50. ANEMIA E DECLINO FUNZIONALE NELL’ANZIANO

Author

BARBAGALLO, Mario, BELLAVIA G, DOMINGUEZ RODRIGUEZ, Ligia Juliana, GALIOTO, Antonio, FERLISI, Annalisa, PUTIGNANO, Ernesto, BELVEDERE, Mario, COSTANZA, Giuseppe, DI SCIACCA, Arnaldo, BARBAGALLO M, BELLAVIA G, DOMINGUEZ LJ, GALIOTO A, FERLISI A, PUTIGNANO E, BELVEDERE M, COSTANZA G, and DI SCIACCA A

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results